For women who have early breast tumors surgically removed, a new genetic test may help predict the odds of a recurrence, a new study says.
I AM A HUMAN AND NOT A ROBOT
⇧ Checking the box is REQUIRED for validation.
Free Dental in Miami-Dade
browardliving.org
To improve and maintain oral health of the medically underserved.
You must be logged in to post a comment.
The research, presented Friday at the San Antonio Breast Cancer Symposium, focused on women with ductal carcinoma in situ.
This refers to abnormal cells in the lining of the milk ducts that may or may not progress to cancer that invades the surrounding breast tissue. Because there is no way of foretelling a progression, surgery is usually performed to remove the abnormality.
In the new study, researchers looked at whether a new test that zeroes in on certain genes can help predict which women will have their ductal carcinoma in situ recur after surgery. The goal is to aid doctors and patients in deciding on further treatment. Read article.